For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231012:nRSL9241Pa&default-theme=true
RNS Number : 9241P IP Group PLC 12 October 2023
FOR RELEASE ON 12 October 2023
IP Group - Webinar on ESG & Impact
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which
invests in breakthrough science and innovation companies with the potential to
create a better future for all, announces that it will hold a webinar on ESG
and impact entitled "ESG Forward - our approach to impact" on Thursday
November 16 2023.
Our Head of ESG, Bran Pathmanāban, will be joined by our CEO Greg Smith and
CFOO David Baynes to discuss the Group's approach to ESG and impact, as well
as the broader challenges of providing a meaningful narrative around impact.
We're delighted to be joined by special guest Alex Edmans, Professor of
Finance at London Business School. Alex has a PhD from MIT as a Fulbright
Scholar and was previously a tenured professor at Wharton and an investment
banker at Morgan Stanley. He serves as non-executive director of the Investor
Forum, on the World Economic Forum's Global Future Council on Responsible
Investing, and on Royal London Asset Management's Responsible Investment
Advisory Committee.
Further details of the event, which will start at 9am, and how to register can
be found on the events section of our website:
https://www.ipgroupplc.com/news-and-events/events
(https://www.ipgroupplc.com/news-and-events/events) .
The update will be hosted live via the Investor Meet Company platform.
Questions can be submitted in advance of the event via the Investor Meet
Company Platform up to 9am the day before the meeting or at any time during
the live presentation. Investors can sign up to Investor Meet Company for free
via: https://www.investormeetcompany.com/ip-group-plc/register-investor
(https://www.investormeetcompany.com/ip-group-plc/register-investor) .
Investors who already follow IP Group plc on the Investor Meet Company
platform will automatically be invited.
No material new information will be released by the Company during the
presentation.
For more information, please contact:
IP Group plc www.ipgroupplc.com
Liz Vaughan-Adams, Communications +44 (0) 20 7444 0062/+44 (0) 7967 312125
Portland
Vic Wallin +44 (0) 7973 823119
Alex Donaldson +44 (0) 7516 729702
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better
future. As the most active UK based, early stage science investor, we
develop and support some of the world's most exciting businesses in
deeptech, life sciences and cleantech (led by Kiko Ventures). Through
Parkwalk, the UK's largest growth EIS fund manager, we also back
world-changing innovation emerging in leading universities and research
institutions. Our specialist investment team combines sector expertise with
an international approach. Together we have a strong track record of success,
having backed high-profile companies including Oxford Nanopore Technologies
plc, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main
Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .
ENDS
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAVLLBFXBLLFBE